Get to know us
As an independent consultancy firm we are supporting biotechs and drug hunters advancing their innovative assets from nonclinical to early clinical development. Investors benefit from our services for critical investment decisions with our unbiased risk/opportunity assessment. We support health care providers to develop and implement clinical decision support tools to treat pediatric cancer patients in a more effective manner.
Our mission
We are changing the way pharmaceutical products are developed and used in clinical practice. As drug developers with experience from biotech, big and midsize pharma companies, we support our customers to develop better medicine for patients with model-based prediction. This enables biotechs and investors to make more informed decisions, to differentiate between promising and inadequate drug candidates, to save time, resources and money and to reduce the number of unnecessary experiments and animal studies and decrease the risk of late stage failure.
Our vision
At tkc suisse, we are passionate about precision medicine and precision dosing as a strategy to improve the overall risk-benefit ratio for all patients. This can have a huge impact on society if side effects were effectively reduced by simply avoiding overdoses in clinical practice. With our expertise in modeling and simulation, tkc suisse bridges the gap between drug development and clinical practice and helps physicians to find the right dose for the individual patient.
